PRICE T ROWE ASSOCIATES INC /MD/ - VISTAGEN THERAPEUTICS INC ownership

VISTAGEN THERAPEUTICS INC's ticker is VTGN and the CUSIP is 92840H202. A total of 117 filers reported holding VISTAGEN THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 1.91 and the average weighting 0.1%.

Quarter-by-quarter ownership
PRICE T ROWE ASSOCIATES INC /MD/ ownership history of VISTAGEN THERAPEUTICS INC
ValueSharesWeighting
Q1 2023$5
+66.7%
33,9590.0%0.00%
Q4 2022$3
-99.9%
33,959
+89.1%
0.00%
Q3 2022$3,000
-96.2%
17,954
-79.9%
0.00%
Q2 2022$79,000
-28.2%
89,354
+1.1%
0.00%
Q1 2022$110,000
-33.3%
88,371
+4.7%
0.00%
Q4 2021$165,000
+7.8%
84,371
+51.0%
0.00%
Q3 2021$153,000
-14.5%
55,871
-1.6%
0.00%
Q2 2021$179,000
+113.1%
56,771
+43.7%
0.00%
Q1 2021$84,00039,5000.00%
Other shareholders
VISTAGEN THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Henrickson Nauta Wealth Advisors, Inc. 200,000$24,9400.02%
GSA CAPITAL PARTNERS LLP 1,275,215$1590.02%
TKG Advisors, LLC 134,860$16,8170.01%
JOHNSON & JOHNSON 190,494$23,7550.01%
GPS Wealth Strategies Group, LLC 253,205$31,5750.01%
Performa Ltd (US), LLC 90,000$11,2230.01%
Jackson Wealth Management, LLC 23,850$2,9740.00%
Garden State Investment Advisory Services LLC 30,000$3,7410.00%
MAI Capital Management 584,925$72,9400.00%
Twin Lakes Capital Management, LLC 12,500$1,5590.00%
View complete list of VISTAGEN THERAPEUTICS INC shareholders